Adequacy and Safety of Liver Biopsy Performed During Cardiac Catheterization in Patients With Fontan and Non-fontan Heart Disease
Liver biopsy during a clinically warranted cardiac catheterization can be safely performed with adequate yield and minimal complication risk. It may be useful in Fontan patients undergoing catheterization to assess Fontan-associated liver disease development.
Authors
- Maria Isabel Fiel (ORCID: https://orcid.org/0000-0002-7314-6313)
- Lauren Tal Grinspan (ORCID: https://orcid.org/0000-0001-7455-280X)
- Thomas Schiano (ORCID: https://orcid.org/0000-0002-9110-0810)
- Ali N. Zaidi (ORCID: https://orcid.org/0000-0002-6303-2355)
- Edward Cytryn (ORCID: https://orcid.org/0009-0007-6985-920X)
- Barry A. Love
- Peizi Li
Institutions
- Mount Sinai Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Gastro Hep Advances
- Published
- 2025-11-08
- DOI
- https://doi.org/10.1016/j.gastha.2025.100841
- Primary Topic
- Congenital Heart Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00